Oncology CME

Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Amir T. Fathi, MD
24 March, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care
Prithviraj Bose, MD
23 March, 2020
Credits: 1.50 CME
Purdue University College of Pharmacy
Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook
William K. Oh, MD
18 March, 2020
Credits: 1.50 CME / MOC
Penn State College of Medicine
Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care
Arjun Balar, MD
17 March, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant
13 March, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
12 March, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Following the Trail of Evidence in VOD Management: How Modern Risk Assessment, Diagnostic Principles, and Treatment Are Improving Care
Mitchell S. Cairo, MD
11 March, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Penn State College of Medicine
Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options
Arjun Balar, MD
10 March, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evidence and Practicalities: Checkpoint Inhibition in Gastrointestinal Cancers—Translating Recent Advances in Gastric, Esophageal, and Colorectal Cancers
Manish A. Shah, MD
9 March, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Developing a Therapeutic Game Plan for the Management of Hepatocellular Carcinoma: Expert Insights From the Patient CaseBook
Richard S. Finn, MD
6 March, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat—Personal Insights on Current Practices and Evolving Standards of Care in Pancreatic Cancer: Expert Perspectives on Implementing State-of-the-Art Care in the Clinic
Johanna C. Bendell, MD
5 March, 2020
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Blazing the Therapeutic Management Trail of Biliary Cancers: Get Prepared for a New Era of Molecular- and Mutation-Driven Treatments
Milind Javle, MD
25 February, 2020
Credits: 2.00 CME
Penn State College of Medicine
Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL
John P. Leonard, MD
28 January, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Maximizing the Benefits and Minimizing the Risks of Cancer Immunotherapies in Everyday Oncology Practice: Need-to-Know Information and Practical Guidance for Oncology Nurses
Marianne Davies, DNP, ACNP, AOCNP
27 January, 2020
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Playbook of Hepatocellular Carcinoma: Examining Scientific Data and Evidence With Your Multidisciplinary Team
Richard S. Finn, MD
13 January, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
31 December, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC
Toni K. Choueiri, MD
31 December, 2019
Credits: 2.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
Andre H. Goy, MD
30 December, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Peter Schmid, FRCP, MD, PhD
30 December, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Enhancing Standards of Care for Patients With Biliary Tract Cancers: A Graphical Guide to Integrating a New Lineup of Targeted Therapies Into Practice
Milind Javle, MD
27 December, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
MasterClass & Tumor Board⁠—Joining Forces in Hepatocellular Carcinoma: Enhancing Multidisciplinary Care in an Era of New Therapeutic Solutions
Amit Singal, MD, MS
24 December, 2019
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Putting Tenosynovial Giant Cell Tumor on Notice: Multidisciplinary Treatment and Implications of New Science
Robin L. Jones, MD
19 December, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Best Practices for Recognizing & Managing Immune-Related Adverse Events in the Emergency Department: Become Aware, Stay Alert, Change Your Practice, & Keep Patients With Cancer Safe
Evan J. Lipson, MD / Andrew Stolbach, MD, MPH
27 November, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
8 November, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble
Ghassan Abou-Alfa, MD, MBA
4 November, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
4 November, 2019
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses
Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP
29 October, 2019
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL
Ian W. Flinn, MD, PhD
28 October, 2019
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Pathology Insights on Innovation in AML: The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care
Carlos E. Bueso-Ramos, MD, PhD
28 October, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence & Clinical Application Across a Range of Solid Malignancies
Matthew T. Ballo, MD, FACR
23 October, 2019

Pages